Avanos Medical, Inc. Announces Third Quarter 2019 Results, Completes Acquisition of Endoclear LLC

Go back to Avanos Medical, Inc. Announces Third Quarter 2019 Results, Completes Acquisition of Endoclear LLC

Avanos Medical, Inc. (AVNS) Misses Q3 EPS by 1c, Lowers Guidance

November 5, 2019 7:26 AM EST

Avanos Medical, Inc. (NYSE: AVNS) reported Q3 EPS of $0.30, $0.01 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $171 million versus the consensus estimate of $179.84 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2019 EPS of $1.00-$1.10, versus the consensus... More